Sebastian Klobuch

9PUBLICATIONS
71CO-AUTHORS
Tumour immunologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|May 18, 2026
Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

|Aug 05, 2025
Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Jessica S W Borgers, Divya Lenkala, Victoria Kohler

|Jan 03, 2025
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Jessica S W Borgers, Divya Lenkala, Victoria Kohler

|Apr 07, 2024
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.

Sumanta K Pal, Ben Tran, John B A G Haanen

|Nov 28, 2022
Human T cells recognize HLA-DP-bound peptides in two orientations.

Sebastian Klobuch, Jia Jia Lim, Peter van Balen

Pageof 2

Frequent Collaborators

4 joint publications

John Haanen

4 joint publications

Inge Jedema

2 joint publications

Sebastian Hymson

2 joint publications

Claudia Gottstein